Literature DB >> 3027401

Characterization of equine infectious anemia virus long terminal repeat.

D Derse, P L Dorn, L Levy, R M Stephens, N R Rice, J W Casey.   

Abstract

The long terminal repeats (LTRs) of equine infectious anemia virus (EIAV) were examined with respect to their ability to function as transcriptional promoters in various cellular environments. Nucleotide sequence analyses of the LTRs derived from two unique proviral clones revealed the requisite consensus transcription and processing signals. One of the proviruses possessed a duplication of a 16-base-pair sequence in the CCAAT box region of the LTR which was absent in the other provirus. To assess its functional activity, each LTR was coupled to the bacterial chloramphenicol acetyltransferase gene and transfected onto various cell lines, including matched cultures of EIAV-infected and uninfected cells. The levels of chloramphenicol acetyltransferase activity directed by the EIAV LTRs were between 250 and 900 times greater in EIAV-infected cells compared with their uninfected counterparts. Thus, EIAV expression appears to be activated by a virus-induced trans-activation phenomenon analogous to that recently shown to amplify expression of certain other lentiviruses.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3027401      PMCID: PMC254015          DOI: 10.1128/JVI.61.3.743-747.1987

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

Review 2.  Form and function of retroviral proviruses.

Authors:  H E Varmus
Journal:  Science       Date:  1982-05-21       Impact factor: 47.728

3.  Gene expression in visna virus infection in sheep.

Authors:  M Brahic; L Stowring; P Ventura; A T Haase
Journal:  Nature       Date:  1981-07-16       Impact factor: 49.962

4.  The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfection.

Authors:  C M Gorman; G T Merlino; M C Willingham; I Pastan; B H Howard
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

5.  Sequencing end-labeled DNA with base-specific chemical cleavages.

Authors:  A M Maxam; W Gilbert
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

6.  Structure, variation and synthesis of retrovirus long terminal repeat.

Authors:  H M Temin
Journal:  Cell       Date:  1981-11       Impact factor: 41.582

7.  Nucleotide sequence of SRV-1, a type D simian acquired immune deficiency syndrome retrovirus.

Authors:  M D Power; P A Marx; M L Bryant; M B Gardner; P J Barr; P A Luciw
Journal:  Science       Date:  1986-03-28       Impact factor: 47.728

8.  In vitro host range of equine infectious anemia virus.

Authors:  C V Benton; B L Brown; J S Harshman; R V Gilden
Journal:  Intervirology       Date:  1981       Impact factor: 1.763

9.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

10.  Efficient infection of monkey cells with DNA of simian virus 40.

Authors:  L M Sompayrac; K J Danna
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

View more
  31 in total

1.  Localization of sequences responsible for trans-activation of the equine infectious anemia virus long terminal repeat.

Authors:  L Sherman; A Gazit; A Yaniv; T Kawakami; J E Dahlberg; S R Tronick
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

2.  Characterization of variable regions in the envelope and S3 open reading frame of equine infectious anemia virus.

Authors:  S Alexandersen; S Carpenter
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

3.  Identification of a hypervariable region in the long terminal repeat of equine infectious anemia virus.

Authors:  S Carpenter; S Alexandersen; M J Long; S Perryman; B Chesebro
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

4.  Genetic variation in the long terminal repeat associated with the transition of Chinese equine infectious anemia virus from virulence to avirulence.

Authors:  Lili Wei; Xiujuan Fan; Xiaoling Lu; Liping Zhao; Wenhua Xiang; Xiaoyan Zhang; Fei Xue; Yiming Shao; Rongxian Shen; Xiaojun Wang
Journal:  Virus Genes       Date:  2009-01-07       Impact factor: 2.332

5.  cis- and trans-acting regulation of gene expression of equine infectious anemia virus.

Authors:  P L Dorn; D Derse
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

6.  Functional organization of the hepatitis B virus enhancer.

Authors:  R Dikstein; O Faktor; R Ben-Levy; Y Shaul
Journal:  Mol Cell Biol       Date:  1990-07       Impact factor: 4.272

7.  Interactions between equine cyclin T1, Tat, and TAR are disrupted by a leucine-to-valine substitution found in human cyclin T1.

Authors:  R Taube; K Fujinaga; D Irwin; J Wimmer; M Geyer; B M Peterlin
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

8.  Cellular factors that interact with the hepatitis B virus enhancer.

Authors:  R Ben-Levy; O Faktor; I Berger; Y Shaul
Journal:  Mol Cell Biol       Date:  1989-04       Impact factor: 4.272

9.  A model for the mechanism of initial generation of short interspersed elements (SINEs).

Authors:  N Okada; K Ohshima
Journal:  J Mol Evol       Date:  1993-08       Impact factor: 2.395

10.  Analysis of regulatory elements of the equine infectious anemia virus and caprine arthritis-encephalitis virus long terminal repeats.

Authors:  L Sherman; A Yaniv; H Lichtman-Pleban; S R Tronick; A Gazit
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.